PRINCETON, NJ -- (MARKET WIRE) -- October 25, 2006 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chief Executive Officer is scheduled to present to the investment community at the Susquehanna Emerging Trends Conference.
